Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0242706 (
hyperoxia
)
5,219
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Exposure of the newborn lung to
hyperoxia
is associated with impaired alveolar development. In newborn rats exposed to
hyperoxia
and studied at day 14 of life, retinoic acid (RA) treatment improved survival and increased lung collagen but did not improve alveolar development. To determine whether RA treatment during exposure to
hyperoxia
results in late improvement in alveolarization, we treated newborn rats with RA and
hyperoxia
from day 3 to day 14 and then weaned O2 to room air by day 20, and studied the animals on day 42. O2-exposed animals had larger mean lung volumes, larger alveoli, and decreased gas-exchange tissue relative to air-exposed animals, whereas RA-treated O2-exposed animals were not statistically different from air-exposed controls. Relative to control animals, elastin staining at day 14 was decreased in
hyperoxia
-exposed lung independent of RA treatment, and, at day 42, elastin staining was similar in all treatment groups. At day 14,
elastin gene
expression was similar in all treatment groups, whereas at day 42 lung previously exposed to
hyperoxia
showed increased elastin signal independent of RA treatment. These results indicate that RA treatment during
hyperoxia
exposure promotes septal formation without evidence of effects on
elastin gene
expression after 4 wk of recovery.
...
PMID:Retinoic acid attenuates O2-induced inhibition of lung septation. 1237 50